http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102584709-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_066af93d226b9a8b1151cb1bc45bd190
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D233-68
filingDate 2011-12-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e2cdf9b96b98ce22fdf769229892ff42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_04446ef8864f9656f56e23a3fd35dcb8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e07549d9f8cfcca63c6a9d1239c3092a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e0dbb5b1d9ef7893b810036df2c27e20
publicationDate 2012-07-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-102584709-A
titleOfInvention A kind of preparation technology of improved eprosartan intermediate aryl imidazole aldehyde
abstract The invention discloses a preparation process of an eprosartan intermediate aryl imidazole aldehyde, that is, methyl esterification of p-chloromethylbenzoic acid is carried out to obtain methyl p-chloromethylbenzoate; Methyl formate and imidazole aldehyde use DMF as the reaction solvent and potassium carbonate as the base to stir and react at 20-40°C; after the reaction is completed, remove potassium carbonate by filtration; add water to the filtrate to crystallize while stirring; recover the aryl group of eprosartan intermediate imidazole aldehyde. The process has the advantages of high yield, high product purity, low N-isomer impurities, extremely low dimer impurities, etc., can be used in the next step without refining, and is suitable for large-scale industrial production.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111978257-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104788382-A
priorityDate 2011-12-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5728842-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H09169738-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2009084028-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5538987-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008078330-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419505696
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5281037

Total number of triples: 22.